Filed under: Featured , News , UFC , Videos A three-member arbitration panel today upheld a standard one-year suspension for Jon Jones ’ UFC 200 drug test failure, rendering the UFC interim light heavyweight champ unable to fight until July 7, 2017, USADA today announced. Jones hoped to receive a reprimand after arguing his positive out-of-competition test – conducted June 16 by UFC anti-doping partner USADA – was caused by a tainted sexual enhancement pill. But according to a press release from USADA, the panel “concluded Jones’ degree of fault was at the very top end of the scale” for a violation on a “specified substance,” in this case the banned estrogen blockers clomiphene and letrozole. Jones, per the panel’s written decision, admitted to taking a pill he “believed to be…’Cialis’” and checked with his agent to make sure it banned, “but which unbeknown, indeed unknowable, by him, was contaminated.” Jones argued he bore “at most a light degree of fault in taking” the pill. The panel disagreed, pointing out Cialis isn’t for performance-enhancement. It also faulted the pill’s manufacturer, reportedly linked to the website AllAmericanPeptide.com, for “standards far less rigorous than those required by the (FDA).” On AllAmericanPeptide.com’s site, several well-known banned performance enhancers appear to be sold under the guide of “research capsules.” An email to the website requesting comment wasn’t immediately returned. The one-year suspension is retroactive to the July 6 date on which Jones was provisionally suspended by USADA.
See the rest here:
Jon Jones gets 1-year suspension from USADA for doping violation stemming from UFC 200 – MMA Junkie